Weiwen XUE - CUHK Research Portal - CONVERIS Research Information System

Go to Header Go to Navigation Go to Content Go to Footer

Dr. XUE Weiwen (No longer affiliated with CUHK)

CUHK Research Outputs

ChIP-seq of mouse primary cultured bone marrow-derived neutrophils stimulated by lung cancer cell conditional medium (2023)

Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma (2023)

Smad3 Mediates Diabetic Dyslipidemia and Fatty Liver in db/db Mice by Targeting PPARδ (2023)

Uncovering Neutrophils as Key Immune Regulators and Translating Their Potential into Next-Generation Anticancer Therapy (2023)

Smad3 Promotes Cancer-Associated Fibroblasts Generation via Macrophage–Myofibroblast Transition (Adv. Sci. 1/2022) (2022)

Smad3 Promotes Cancer-Associated Fibroblasts Generation via Macrophage–Myofibroblast Transition (2022)

Smad3 deficiency promotes beta cell proliferation and function in db/db mice via restoring Pax6 expression (2021)

USMB-shMincle: a virus-free gene therapy for blocking M1/M2 polarization of tumor-associated macrophages (2021)

Macrophage-specific RNA-sequencing reveals a novel pathogenic mechanism for malignancy-associated acute kidney injury at single-cell resolution (2020)

Neural transcription factor Pou4f1 promotes renal fibrosis via macrophage-myofibroblast transition (2020)

The Mincle/Syk/NF-κB Signalling Circuit is Essential for Maintaining the Protumoral Activities of Tumor-associated Macrophages (2020)

Transforming Growth Factor-β: A Multifunctional Regulator of Cancer Immunity (2020)

Smad3 Shortens the Lifespan of Neutrophil in the Tumor Microenvironment (2019)